Pictet Asset Management (UK)’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
Other funds holding CELL
AIM
SUT
FAM
Pictet Asset Management (UK)'s CELL Position: Q2 2021 in Review
Pictet Asset Management (UK) reduced its PhenomeX Inc. Common Stock (CELL) stake by 3.6% in Q2 2021, selling an estimated $447K and leaving 254,783 shares worth $11.4M. The position accounts for 0.01% of the portfolio, ranked #653.
Pictet Asset Management (UK) first reported a position in CELL in Q1 2021 and has held it in 2 quarters since. The position peaked at $13.3M in Q1 2021. 156 funds tracked by Wall St. Rank hold CELL as of Q2 2021.
- Pictet Asset Management (UK) held 254,783 shares of PhenomeX Inc. Common Stock worth $11.4M as of Q2 2021.
- Pictet Asset Management (UK) sold 9,644 PhenomeX Inc. Common Stock shares in Q2 2021, an estimated $447K.
- PhenomeX Inc. Common Stock made up 0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #653 holding.
- Pictet Asset Management (UK) first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and has held it in 2 quarters since.
- Pictet Asset Management (UK)'s PhenomeX Inc. Common Stock position peaked at $13.3M in Q1 2021.
- 156 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2021.
Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.